Literature DB >> 22379025

Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.

Benjamin Cieply1, Philip Riley, Phillip M Pifer, Joseph Widmeyer, Joseph B Addison, Alexey V Ivanov, James Denvir, Steven M Frisch.   

Abstract

Grainyhead genes are involved in wound healing and developmental neural tube closure. In light of the high degree of similarity between the epithelial-mesenchymal transitions (EMT) occurring in wound-healing processes and the cancer stem cell-like compartment of tumors, including TGF-β dependence, we investigated the role of the Grainyhead gene, Grainyhead-like-2 (GRHL2) in oncogenic EMT. GRHL2 was downregulated specifically in the claudin-low subclass breast tumors and in basal-B subclass breast cancer cell lines. GRHL2 suppressed TGF-β-induced, Twist-induced or spontaneous EMT, enhanced anoikis sensitivity, and suppressed mammosphere generation in mammary epithelial cells. These effects were mediated in part by suppression of ZEB1 expression via direct repression of the ZEB1 promoter. GRHL2 also inhibited Smad-mediated transcription and it upregulated mir-200b/c as well as the TGF-β receptor antagonist, BMP2. Finally, ectopic expression of GRHL2 in MDA-MB-231 breast cancer cells triggered an MET and restored sensitivity to anoikis. Taken together, our findings define a major role for GRHL2 in the suppression of oncogenic EMT in breast cancer cells. ©2012 AACR

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379025      PMCID: PMC3342427          DOI: 10.1158/0008-5472.CAN-11-4038

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Evidence for a function of CtBP in epithelial gene regulation and anoikis.

Authors:  M L Grooteclaes; S M Frisch
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

2.  The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex.

Authors:  Max Werth; Katharina Walentin; Annekatrin Aue; Jörg Schönheit; Anne Wuebken; Naomi Pode-Shakked; Larissa Vilianovitch; Bettina Erdmann; Benjamin Dekel; Michael Bader; Jonathan Barasch; Frank Rosenbauer; Friedrich C Luft; Kai M Schmidt-Ott
Journal:  Development       Date:  2010-11       Impact factor: 6.868

Review 3.  Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing.

Authors:  Coert Margadant; Arnoud Sonnenberg
Journal:  EMBO Rep       Date:  2010-01-15       Impact factor: 8.807

4.  Grainyhead and Zelda compete for binding to the promoters of the earliest-expressed Drosophila genes.

Authors:  Melissa M Harrison; Michael R Botchan; Thomas W Cline
Journal:  Dev Biol       Date:  2010-07-01       Impact factor: 3.582

5.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Authors:  Chad J Creighton; Xiaoxian Li; Melissa Landis; J Michael Dixon; Veronique M Neumeister; Ashley Sjolund; David L Rimm; Helen Wong; Angel Rodriguez; Jason I Herschkowitz; Cheng Fan; Xiaomei Zhang; Xiaping He; Anne Pavlick; M Carolina Gutierrez; Lorna Renshaw; Alexey A Larionov; Dana Faratian; Susan G Hilsenbeck; Charles M Perou; Michael T Lewis; Jeffrey M Rosen; Jenny C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

6.  Regional neural tube closure defined by the Grainy head-like transcription factors.

Authors:  Yeliz Rifat; Vishwas Parekh; Tomasz Wilanowski; Nikki R Hislop; Alana Auden; Stephen B Ting; John M Cunningham; Stephen M Jane
Journal:  Dev Biol       Date:  2010-07-21       Impact factor: 3.582

Review 7.  The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Authors:  Molly A Taylor; Jenny G Parvani; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-15       Impact factor: 2.673

8.  Binding of the RING polycomb proteins to specific target genes in complex with the grainyhead-like family of developmental transcription factors.

Authors:  Annabel Tuckfield; David R Clouston; Tomasz M Wilanowski; Lin-Lin Zhao; John M Cunningham; Stephen M Jane
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

9.  Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

Authors:  Vidya Ganapathy; Rongrong Ge; Alison Grazioli; Wen Xie; Whitney Banach-Petrosky; Yibin Kang; Scott Lonning; John McPherson; Jonathan M Yingling; Swati Biswas; Gregory R Mundy; Michael Reiss
Journal:  Mol Cancer       Date:  2010-05-26       Impact factor: 27.401

10.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.

Authors:  Ulrich Wellner; Jörg Schubert; Ulrike C Burk; Otto Schmalhofer; Feng Zhu; Annika Sonntag; Bettina Waldvogel; Corinne Vannier; Douglas Darling; Axel zur Hausen; Valerie G Brunton; Jennifer Morton; Owen Sansom; Julia Schüler; Marc P Stemmler; Christoph Herzberger; Ulrich Hopt; Tobias Keck; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

View more
  105 in total

1.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

Review 2.  Roles of Grainyhead-like transcription factors in cancer.

Authors:  S M Frisch; J C Farris; P M Pifer
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

3.  Grainyhead-like 2 downstream targets act to suppress epithelial-to-mesenchymal transition during neural tube closure.

Authors:  Heather J Ray; Lee A Niswander
Journal:  Development       Date:  2016-02-22       Impact factor: 6.868

4.  Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Authors:  Rachel A Davidowitz; Laura M Selfors; Marcin P Iwanicki; Kevin M Elias; Alison Karst; Huiying Piao; Tan A Ince; Michael G Drage; Judy Dering; Gottfried E Konecny; Ursula Matulonis; Gordon B Mills; Dennis J Slamon; Ronny Drapkin; Joan S Brugge
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

5.  DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.

Authors:  C Pistore; E Giannoni; T Colangelo; F Rizzo; E Magnani; L Muccillo; G Giurato; M Mancini; S Rizzo; M Riccardi; N Sahnane; V Del Vescovo; K Kishore; M Mandruzzato; F Macchi; M Pelizzola; M A Denti; D Furlan; A Weisz; V Colantuoni; P Chiarugi; I M Bonapace
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

Review 6.  Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer.

Authors:  Michal Mlacki; Agnieszka Kikulska; Ewa Krzywinska; Magdalena Pawlak; Tomasz Wilanowski
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-10

Review 7.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 8.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.

Authors:  Jason A Somarelli; Samantha Shetler; Mohit K Jolly; Xueyang Wang; Suzanne Bartholf Dewitt; Alexander J Hish; Shivee Gilja; William C Eward; Kathryn E Ware; Herbert Levine; Andrew J Armstrong; Mariano A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2016-09-12       Impact factor: 4.272

10.  Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.

Authors:  Qi Zhao; Otavia L Caballero; Ian D Davis; Eric Jonasch; Pheroze Tamboli; W K Alfred Yung; John N Weinstein; Robert L Strausberg; Jun Yao
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.